Prognostic Value of Rubidium-82 Positron Emission Tomography in Patients After Heart TransplantBrian A. Mc Ardle, Benjamin J.W. Chow, Renée Hessian et al.|Circulation Cardiovascular Imaging|2014Cited by 119
The role of F18-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosisBrian A. Mc Ardle, Pablo B. Nery, E. Leung et al.|Journal of Nuclear Cardiology|2013Cited by 87
LONG TERM FOLLOW UP OF OUTCOMES WITH F-18-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY IMAGING- ASSISTED MANAGEMENT OF PATIENTS WITH SEVERE LEFT VENTRICULAR DYSFUNCTION SECONDARY TO CORONARY DISEASE: 5-YEAR FOLLOW-UP OF THE PARR-2 RANDOMIZED CONTROLLED TRIALTushar Shukla, R.S. Beanlands, Brian A. Mc Ardle et al.|Canadian Journal of Cardiology|2014Cited by 3
Abstract 13207: Long term Follow-up of Outcomes with F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging- Assisted Management of Patients with Severe Left Ventricular dysfunction Secondary to Coronary DiseaseBrian A. Mc Ardle, Rob Beanlands, Tushar Shukla et al.|Unknown|2014Cited by 1
Abstract 10987: Is There an Association Between Myocardial Flow Reserve as Measured on Rubidium-82 Positron Emission Tomography and Allograft Rejection in Patients Following Cardiac Transplantation?Brian A. Mc Ardle, Benjamin J.W. Chow, Ross A. Davies et al.|Circulation|2013Cited by 0